Testing effectiveness (Phase 2)Study completedNCT05575492
What this trial is testing
MRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Years of Age
Who this might be right for
Cytomegalovirus
ModernaTX, Inc. 873